Personal information

Emails & domains

Verified email domains

Other IDs

ResearcherID: F-4188-2019

Activities

Collapse all

Employment (3)

CRCI2NA, INSERM: Angers, FR

2016-11-02 to present (Equipe 4)
Employment
Source: Self-asserted source
Damien Luque Paz

Université Angers UFR Sciences: Angers, Pays de la Loire, FR

2015-11-02 to present
Employment
Source: Self-asserted source
Damien Luque Paz

Centre Hospitalier Universitaire de Angers: Angers, FR

2015-11-02 to present (Hematology Laboratory)
Employment
Source: Self-asserted source
Damien Luque Paz

Education and qualifications (3)

University of Angers: Angers, FR

2017-11 to 2020-05 | Ph.D. (École doctorale Biologie Santé)
Education
Source: Self-asserted source
Damien Luque Paz

University of Rennes 1: Rennes, FR

2006-11 to 2015-11 | Pharm. D. (UFR Pharmacie)
Education
Source: Self-asserted source
Damien Luque Paz

University of Rennes 1: Rennes, FR

2010-11-02 to 2015-10-30 | DES Biologie Médicale (UFR Pharmacie)
Education
Source: Self-asserted source
Damien Luque Paz

Works (50)

Tailored Digital PCR Follow-Up of Rare Fusion Transcripts after Initial Detection through RNA Sequencing in Hematological Malignancies.

The Journal of molecular diagnostics : JMD
2024-08 | Journal article
DOI: 10.1016/j.jmoldx.2024.07.004
PMID: 39182671
Contributors: Boulland ML; Aliouat A; Jalaber E; Desmares A; Toujani S; Luque Paz D; Wiber M; Voirin E; Lachot S; Basinko A et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F-positive myeloproliferative neoplasms.

Blood
2024-06 | Journal article
DOI: 10.1182/blood.2023020270
PMID: 38493481
Contributors: Usart M; Stetka J; Luque Paz D; Hansen N; Kimmerlin Q; Almeida Fonseca T; Lock M; Kubovcakova L; Karjalainen R; Hao-Shen H et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Haematologica
2024-06 | Journal article
DOI: 10.3324/haematol.2023.284488
PMID: 38328854
PMC: PMC11141647
Contributors: Galtier J; Drevon L; Le Bris Y; Giraudier S; Wemeau M; Legros L; Luque Paz D; Girodon F; Kiladjian JJ; Mesguich C et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis.

American journal of hematology
2024-05 | Journal article
DOI: 10.1002/ajh.27368
PMID: 38752375
Contributors: Voirin E; Bouvier A; Plo I; Durix L; Beucher A; Giraudier S; Ugo V; Brasme JF; Luque Paz D
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2-V617F–positive myeloproliferative neoplasms∗

Blood
2024-03 | Journal article
PMC: PMC11208296
Contributors: Usart M; Stetka J; Luque Paz D; Hansen N; Kimmerlin Q; Almeida Fonseca T; Lock M; Kubovcakova L; Karjalainen R; Hao-Shen H et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Blood smear invaders: About a fatal case of bacteremia.

International journal of laboratory hematology
2024-02 | Journal article
DOI: 10.1111/ijlh.14256
PMID: 38409950
Contributors: Bauduin A; Demoy M; Genevieve F; Tuffigo M; Luque Paz D; Boussaroque A
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.

American journal of hematology
2024-02 | Journal article
DOI: 10.1002/ajh.27265
PMID: 38404143
Contributors: Aubin L; Vilas Boas R; Daltro De Oliveira R; Le Brun V; Divoux M; Rey J; Mansier O; Ianotto JC; Pastoret C; Desmares A et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells

Blood advances
2024-01 | Journal article
PMC: PMC10912850
Contributors: Rai S; Zhang Y; Grockowiak E; Kimmerlin Q; Hansen N; Stoll C; Usart M; Luque Paz D; Hao-Shen H; Zhu Y et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.

Blood advances
2024-01 | Journal article
DOI: 10.1182/bloodadvances.2023011338
PMID: 38207211
Contributors: Rai S; Zhang Y; Grockowiak E; Kimmerlin Q; Hansen N; Stoll CB; Usart M; Luque Paz D; Hao-Shen H; Zhu Y et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Leukemia
2023-12 | Journal article
DOI: 10.1038/s41375-023-02114-5
PMID: 38148396
Contributors: Pasquer H; Daltro de Oliveira R; Vasseur L; Soret-Dulphy J; Maslah N; Zhao LP; Marcault C; Cazaux M; Gauthier N; Verger E et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.

HemaSphere
2023-08 | Journal article
DOI: 10.1097/hs9.0000000000000943
PMID: 37637995
PMC: PMC10455455
Contributors: Darlington M; Sujobert P; Kosmider O; Luque Paz D; Kaltenbach S; Figeac M; Hayette S; Mezaour N; Coquerelle S; Alary AS et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms.

HemaSphere
2023-05 | Journal article
DOI: 10.1097/hs9.0000000000000885
PMID: 37153874
PMC: PMC10158927
Contributors: Luque Paz D; Bader MS; Nienhold R; Rai S; Almeida Fonseca T; Stetka J; Hao-Shen H; Mild-Schneider G; Passweg JR; Skoda RC
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Genetic basis and molecular profiling in myeloproliferative neoplasms.

Blood
2023-04 | Journal article
DOI: 10.1182/blood.2022017578
PMID: 36347013
Contributors: Luque Paz D; Kralovics R; Skoda RC
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores.

American journal of hematology
2023-04 | Journal article
DOI: 10.1002/ajh.26917
PMID: 36964937
Contributors: Bachelot A; Bouvier A; Riou J; Thepot S; Giltat A; Nunes Gomes C; Paillassa J; Jouanneau-Courville R; Renard M; Beucher A et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Histological and genetic characterization and follow-up of 130 patients with chronic triple-negative thrombocytosis.

Haematologica
2022-11 | Journal article
DOI: 10.3324/haematol.2022.280917
PMID: 35833299
Contributors: Lemoine S; Mornet C; Quintin-Roue I; Rousselet MC; Cottin L; Georgeais A; Dubouis L; Boyer F; Orvain C; Caillon C et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.

Nature communications
2022-09 | Journal article
DOI: 10.1038/s41467-022-32927-4
PMID: 36100613
PMC: PMC9470591
Contributors: Rai S; Grockowiak E; Hansen N; Luque Paz D; Stoll CB; Hao-Shen H; Mild-Schneider G; Dirnhofer S; Farady CJ; Méndez-Ferrer S et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.

Blood cancer journal
2022-04 | Journal article
DOI: 10.1038/s41408-022-00646-0
PMID: 35395836
PMC: PMC8993923
Contributors: Sureau L; Buors C; Ianotto JC; Boyer F; Tanguy-Schmidt A; Roy L; Cayssials E; Cailly L; Chomel JC; Chauveau A et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience

HemaSphere
2021-11 | Journal article
PMC: PMC8598224
Contributors: Alary A; Maute C; Kosmider O; Sujobert P; Gauthier A; Macintyre E; Preudhomme C; Hayette S; Luque-Paz D; Baran-Marszak F et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.

Annals of hematology
2021-10 | Journal article
DOI: 10.1007/s00277-021-04672-z
PMID: 34611719
Contributors: Paz DL; Cottin L; Lippert E; Robin JB; Bescond C; Genevieve F; Boyer F; Quintin-Roue I; Rousselet MC; Burroni B et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO).

American journal of hematology
2021-07 | Journal article
DOI: 10.1002/ajh.26274
PMID: 34152612
Contributors: Lazarian G; Munger M; Quinquenel A; Dilhuydy MS; Veronese L; Luque Paz D; Guièze R; Ledoux-Pilon A; Paillassa J; Merabet F et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Efficacy and tolerability of Janus kinase inhibitors in myelofibrosis: a systematic review and network meta-analysis.

Blood cancer journal
2021-07 | Journal article
DOI: 10.1038/s41408-021-00526-z
PMID: 34315858
PMC: PMC8316412
Contributors: Sureau L; Orvain C; Ianotto JC; Ugo V; Kiladjian JJ; Luque Paz D; Riou J
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

No detection of atypical one-base deletion of CALR exon 9 with fragment analysis: A molecular trap to avoid.

Blood cells, molecules & diseases
2021-06 | Journal article
DOI: 10.1016/j.bcmd.2021.102589
PMID: 34214802
Contributors: Lemoine S; Renard M; Bouvier A; Orvain C; Giltat A; Cottin L; Blanchet O; Hunault-Berger M; Ugo V; Luque Paz D
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.

Blood advances
2021-03 | Journal article
DOI: 10.1182/bloodadvances.2020003444
PMID: 33666653
Contributors: Luque Paz D; Riou J; Verger E; Cassinat B; Chauveau A; Ianotto JC; Dupriez B; Boyer F; Renard M; Mansier O et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Myeloproliferative Neoplasms: The Long Wait for JAK2-Mutant Clone Expansion.

Cell stem cell
2021-03 | Journal article
DOI: 10.1016/j.stem.2021.02.018
PMID: 33667352
Contributors: Luque Paz D; Ashcroft P; Skoda RC
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Deep learning shows no morphological abnormalities in neutrophils in Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)
2021-02 | Journal article
DOI: 10.1002/dad2.12146
PMID: 33665339
Contributors: Chabrun F; Dieu X; Doudeau N; Gautier J; Luque-Paz D; Geneviève F; Ferré M; Mirebeau-Prunier D; Annweiler C; Reynier P
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality.

Blood
2021-02 | Journal article
DOI: 10.1182/blood.2020005563
PMID: 33667305
Contributors: Rao TN; Hansen N; Stetka J; Luque Paz D; Kalmer M; Hilfiker J; Endele M; Ahmed N; Kubovcakova L; Rybarikova M et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation.

Blood advances
2020-10 | Journal article
DOI: 10.1182/bloodadvances.2020002271
PMID: 33035330
PMC: PMC7556129
Contributors: Luque Paz D; Jouanneau-Courville R; Riou J; Ianotto JC; Boyer F; Chauveau A; Renard M; Chomel JC; Cayssials E; Gallego-Hernanz MP et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.

Leukemia
2020-07 | Journal article
DOI: 10.1038/s41375-020-0991-x
PMID: 32694617
Contributors: Tondeur S; Paul F; Riou J; Mansier O; Ranta D; Le Clech L; Lippert E; Tavitian S; Chaoui D; Mercier M et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Diagnosis and prognosis are comforted by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.

Haematologica
2020-04 | Journal article
DOI: 10.3324/haematol.2019.242677
PMID: 32241844
Contributors: Vantyghem S; Peterlin P; Thépot S; Ménard A; Dubruille V; Debord C; Guillaume T; Garnier A; Le Bourgeois A; Wuilleme S et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Detection of intrinsic pathway factor deficiency associated with bleeding risk by kaolin-based aPTT.

International journal of laboratory hematology
2020-01 | Journal article
DOI: 10.1111/ijlh.13149
PMID: 31904896
Contributors: Mornet C; Luque Paz D; Lippert E; Galinat H; Mingant F
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Leukemia
2019-11 | Journal article
DOI: 10.1038/s41375-019-0624-4
PMID: 31768015
Contributors: Bouvier A; Riou J; Thépot S; Sutra Del Galy A; François S; Schmidt A; Orvain C; Estienne MH; Villate A; Luque Paz D et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.

British journal of haematology
2019-11 | Journal article
DOI: 10.1111/bjh.16276
PMID: 31710700
Contributors: Cottin L; Riou J; Orvain C; Ianotto JC; Boyer F; Renard M; Truchan-Graczyk M; Murati A; Jouanneau-Courville R; Allangba O et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Targeted molecular characterization shows differences between primary and secondary myelofibrosis.

Genes, chromosomes & cancer
2019-07 | Journal article
DOI: 10.1002/gcc.22789
PMID: 31340059
Contributors: Courtier F; Garnier S; Carbuccia N; Guille A; Adélaide J; Chaffanet M; Hirsch P; Luque Paz D; Slama B; Vey N et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Next generation sequencing redefines a triple negative essential thrombocythaemia as double-positive with rare mutations on JAK2 V617 and MPL W515 hotspots.

British journal of haematology
2019-05 | Journal article
DOI: 10.1111/bjh.15954
PMID: 31087331
Contributors: Beucher A; Dib M; Orvain C; Bouvier A; Jouanneau-Courville R; Dobo I; Cottin L; Guardiola P; Rousselet MC; Blanchet O et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis.

Blood cells, molecules & diseases
2018-12 | Journal article
DOI: 10.1016/j.bcmd.2018.12.004
PMID: 30612065
Contributors: Cottin L; Riou J; Boyer F; Bouvier A; Zannetti A; Blouet A; Truchan-Graczyk M; Jouanneau-Courville R; Beucher A; Ribourtout B et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.

BMC cancer
2018-11 | Journal article
DOI: 10.1186/s12885-018-4993-2
PMID: 30419846
PMC: PMC6233495
Contributors: Dumas PY; Mansier O; Prouzet-Mauleon V; Koya J; Villacreces A; Brunet de la Grange P; Luque Paz D; Bidet A; Pasquet JM; Praloran V et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience.

Haematologica
2018-10 | Journal article
DOI: 10.3324/haematol.2018.197699
PMID: 30337359
PMC: PMC6442979
Contributors: Luque Paz D; Mansier O; Riou J; Conejero C; Roy L; Belkhodja C; Ugo V; Giraudier S
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation.

European journal of haematology
2018-09 | Journal article
DOI: 10.1111/ejh.13143
PMID: 30007088
Contributors: Bouvier A; Ribourtout B; François S; Orvain C; Paz DL; Beucher A; Guérard A; Guardiola P; Ugo V; Blanchet O et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Concomitant CALR and LNK mutations leading to essential thrombocythemia with erythrocytosis.

Blood cells, molecules & diseases
2018-04 | Journal article
DOI: 10.1016/j.bcmd.2018.04.002
PMID: 29703677
Contributors: Luque Paz D; Boyer F; Beucher A; Bouvier A; Jouanneau-Courville R; Guardiola P; Lambert D; Delneste Y; Hunault M; Blanchet O et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Clinical and biological characterization of MPN patients harboring two driver mutations, a French intergroup of myeloproliferative neoplasms (FIM) study.

American journal of hematology
2018-01 | Journal article
DOI: 10.1002/ajh.25014
PMID: 29266414
Contributors: Mansier O; Luque Paz D; Ianotto JC; Le Bris Y; Chauveau A; Boyer F; Conejero C; Fitoussi O; Riou J; Adiko D et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia.

HemaSphere
2018-01 | Journal article
DOI: 10.1097/HS9.0000000000000029
PMID: 31723757
PMC: PMC6745955
Contributors: Blouet A; Rousselet MC; Le Bris Y; Ribourtout B; Bouvier A; Cottin L; Jouanneau-Courville R; Blanchet O; Ugo V; Luque Paz D
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Sequential analysis of 18 genes in polycythemia vera and essential thrombocythemia reveals an association between mutational status and clinical outcome.

Genes, chromosomes & cancer
2017-02 | Journal article
DOI: 10.1002/gcc.22437
PMID: 27997717
Contributors: Luque Paz D; Chauveau A; Boyer F; Buors C; Samaison L; Cottin L; Seegers V; Férec C; Le Maréchal C; Gueguen P et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Absence of CALR mutations in JAK2-negative polycythemia.

Haematologica
2016-10 | Journal article
DOI: 10.3324/haematol.2016.154799
PMID: 27758825
PMC: PMC5210252
Contributors: Chauveau A; Nibourel O; Tondeur S; Paz DL; Mansier O; Paul F; Wemeau M; Preudhomme C; Lippert E; Ugo V et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study.

Annals of hematology
2016-09 | Journal article
DOI: 10.1007/s00277-016-2784-x
PMID: 27582015
Contributors: Orvain C; Luque Paz D; Dobo I; Cottin L; Le Calvez G; Chauveau A; Mercier M; Farhi J; Boyer F; Ianotto JC et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes.

Cellular & molecular immunology
2016-08 | Journal article
DOI: 10.1038/cmi.2016.42
PMID: 27499044
PMC: PMC5811677
Contributors: Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G et al.
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Extinction of myeloproliferative neoplasm by acquisition of a lymphoid disease: JAK2 (V617F) and JAK2 exon 12 allele burden disappearance during the follow-up of two patients.

Annals of hematology
2015-11 | Journal article
DOI: 10.1007/s00277-015-2559-9
PMID: 26611851
Contributors: Mahé K; Luque Paz D; Couturier MA; Chauveau A; Quintin-Roué I; Berthou C; Ugo V; Lippert E; Ianotto JC
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Expansion of a BCR-ABL clone in a JAK2 V617F myeloproliferative neoplasm treated by ruxolitinib.

Annals of hematology
2015-10 | Journal article
DOI: 10.1007/s00277-015-2518-5
PMID: 26459144
Contributors: Luque Paz D; Ianotto JC; Chauveau A; Guibourg B; Lecucq L; Lippert E; Ugo V
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

Absence of CALR mutation among a cohort of 394 unselected patients with a first episode of unprovoked venous thromboembolism.

Thrombosis and haemostasis
2015-08 | Journal article
DOI: 10.1160/th15-02-0134
PMID: 26290216
Contributors: Ianotto JC; Chauveau A; Luque Paz D; Delluc A; Tromeur C; Couturier MA; Gouillou M; Berthou C; Mottier D; Ugo V
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

A new point mutation in EPOR inducing a short deletion in congenital erythrocytosis.

British journal of haematology
2015-05 | Journal article
DOI: 10.1111/bjh.13511
PMID: 26010769
Contributors: Chauveau A; Luque Paz D; Lecucq L; Le Gac G; Le Maréchal C; Gueguen P; Berthou C; Ugo V
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central

[Classification of urinary calculi in a pediatric population from Brittany].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
2013-04 | Journal article
DOI: 10.1016/j.purol.2013.03.010
PMID: 24034803
Contributors: Luque Paz D; Meskar A; Kerspern H; Bordron A; Carré JL
Source: Self-asserted source
Damien Luque Paz via Europe PubMed Central
How many people are using ORCID?